Bacillus Coagulans Effect on Gastrointestinal Function in Healthy Adults.
← catalyst calendarSponsored by Kerry Group P.L.C (industry) · KYGA.L — their whole pipeline →. With Beijing Hospital.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Randomized · Quadruple · Other
Enrollment
111actual
Sites
1
Country
China
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-25
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-07-01 | actual | When the study began enrolling |
| Primary completion | 2021-10-30 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2021-10-30 | actual | The whole study's end, after follow-up |
| First posted | 2024-10-16 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-10-16 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Digestive Discomfort
- Constipation
- Microbiota
Interventions
- Dietary supplement: Bacillus coagulans GBI-30,6086 (BC GBI-30)
- Dietary supplement: Placebo
Primary outcomes
what the primary-completion date above is the date OFStool frequency
measured 6 weeks period, from enrollment to the end of the study.
Stool consistency.
measured 6 weeks period, from enrollment to the end of the study.
Improvement of constipation rate
measured 6 weeks period, from enrollment to the end of the study.
Improvement in the defection effort
measured 6 weeks period, from enrollment to the end of the study.
Changes in intestinal microbiota
measured 4 weeks period, assessment at Day 0, Day 14 and Day28
Improvement in digestive symptoms scores
measured 6 weeks; assessment at Day 0, Day 14 and Day 28
Improvement in upper GI symptoms
measured 6 weeks; assessment at Day 0, Day 14 and Day 28
Publications
- PMID 40707016 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Related
KYGA.L's other studiesmost recently updated first
- Sleep Promoting Properties of a Botanical Extract in a Population Complaining From Non-Restorative Sleep (NRS) Not applicable · Recruiting
- Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs Not applicable · Completed
- Effect of Bacillus Subtilis ATCC 122264 Supplementation on Gas Symptoms and Quality of Life in Participants With Functional Bloating Not applicable · Completed
Permalink · KYGA.L's whole pipeline · Catalyst calendar · Every registered study · What changed